alexa Mitsugu Fujita | Kindai University Graduate School of M
ISSN: 2161-0940

Anatomy & Physiology: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Mitsugu Fujita

Mitsugu Fujita Mitsugu Fujita Departments of Microbiology and Acute Medicine Kindai University Graduate School of Medical Sciences Japan
Biography

Dr. Mitsugu Fujita received his medical degree in 1997 from Nagoya University School of Medicine, where he became interested in the central nervous system and brain diseases. He completed his internship in 1999 and neurosurgical residency in 2001 at Nagoya Daini Red Cross Hospital, Nagoya, Japan and has been certified by the Board of Neurosurgery in Japan in 2003. He has also received his Ph.D. degree in Neurosurgery from Nagoya University Graduate School of Medicine in 2004, where he began to dedicate himself to brain tumor research.Dr. Fujita held the position of Neurosurgeon-in-Chief at Konan Kosei Hospital, Aichi, Japan until he joined the Department of Neurological Surgery at the University of Pittsburgh, PA as a Visiting Research Associate in 2006. He was promoted to Research Instructor in 2008 and Assistant Professor in 2009. When he came back to Japan, he was appointed Section Head of Immunology and Neurosurgery at Aichi Cancer Center, Nagoya, Japan in 2011. Since 2012, he has worked as Associate Professor of Microbiology at Kindai University Faculty of Medicine, Osaka, Japan.Dr. Fujita currently conducts basic and translational research and focuses on brain tumor immunology and immunotherapy. He has investigated the therapeutic significance of T lymphocytes and dendritic cells as therapeutic targets in brain tumors in humans and animal models. His work has recently extended into the field of immune-mediated neurological disorders.

Research Interest

Cell Therapy, Immunotherapy, Neurosurgery, Neuro-Oncology, Cancer Immunology, Cancer Vaccine, Cancer Virology, Epidemiology, Medical Statistics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords